Join Index

Explore

Streams

Products

About Index

Index

By TNW

Pharmaceuticals

600+ Companies

Parent markets

Sibling markets

Related markets

600+ companies in Pharmaceuticals
Show all

Merck

AbbVie

Biotechnology +1

GlaxoSmithKline

Health and Wellness +2

Allergan plc

Biotechnology +1

Sanofi

Pharmaceuticals

Roche

Biotechnology +3

TransEnterix

AstraZeneca

Biotechnology +1

Takeda

Intrexon

Biotechnology +2

Bristol-Myers Squibb

Health and Wellness +2

Novo Nordisk

Biotechnology +1

Galena Biopharma

Biotechnology +1

AlternaCare

Cellectar

Biotechnology +1

All companies in Pharmaceuticals

Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing

Built with ❤︎ by Datalicious ©2018
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

News

Funding rounds

Acquisitions

Companies

Investors

Companies

664

Established hub

Deals 2018 Q3

21 investments

2 acquisitions

Index Pro Account

Upgrade your account to download a CSV export of companies on any list

Upgrade account

Checkmate Pharmaceuticals Closes $22M Financing

To Cover Debts, Synergy Inks $200M Bankruptcy Sale to Bausch Health

$18,000,000 Venture capital (Series A)

Spring Discovery rallies $18 mln Series A

Roche Vet O’Day Tapped To Shape Gilead’s Future As Hep C Sales Fall

Imfinzi looks flimsy in AstraZeneca's Phase III head and neck cancer study

Viracta, Neurelis & More: The Latest in San Diego Biotech

$21,000,000 Venture capital (Series B)

,

Kallyope Raises $21M Expansion of Series B Financing

Venture capital (Series A)

Vast Therapeutics Closes Series A Funding

GSK slides after buying cancer firm Tesaro for hefty $5.1 billion: Reuters

€1,200,000 Crowdfunding

AbilityPharma raises €1.2M to develop drug for cancer

Variant Pharmaceuticals Secures $10M in Financing

Unilever wins race for GSK's consumer healthcare biz in India

Hildred-backed Crown Laboratories acquires five OTC consumer brands from GSK

$30,000,000 Venture capital

Nevakar Completes $30M Financing

$30,000,000 Venture capital (Series B)

Shine Raises $30M, Could Add $150M More After Inking Deerfield Deal

VC-backed Rgenix expands board with new addition

X4 Pharma Heads to Nasdaq Via Reverse Merger with Arsanis

VC-backed BlueRock Therapeutics names chief legal and administrative officer

Centrexion Therapeutics changes its mind on initial public offering

AstraZeneca sells US rights to RSV drug to Swedish firm for $1.5B